Studies on MORA-therapy

Studies used in the following indication - or reference listing to prove an indication complies with at least two points of the following admission criteria:

 

  • There is at least one positive study higher than the AHA compliant level 3  available.
  • At least one study has been published in a recognised peer-review journal.
  • The positive study result has been reproduced at least once by other independent authors.
Human studies

Indication

Functional gastro-intestinal

disorder (none-organic gastritis and irritable colon)

Reference

Nienhaus (1999):

retrospective, uncontrolled case series in bei psychosomatic problems (including functional gastro-intestinal disorders), conducted with MORA-Super device MORA-Super-Gerät, practical trial

AHA evidence level : level 5

 

Nienhaus (2003):

controlled clinical study with clinical test plan, full documentation and case reports (sponsor: MedTronik GmbH), conducted with MORA-Super device, clinical trial.

published: Nienhaus und Galle 2006, Medline, peer-reviewed

AHA evidence level : level 2

 

Therapy of intolerances and allergies

Morell (1988):

prospective, non-comparative clinical application study, conducted with MORA-Super device, clinical trial

AHA evidence level : level 5

 

Schumacher (1994, 1998):

prospective, non-comparative application study, conducted with MORA-III device, clinical trial

AHA evidence level: level 5

 

Hennecke (1994):

retrospective, non-comparative, clinical application study, conducted with BICOM-device, clinical trial

AHA evidence level: level 5

 

Chervinskaya et al. (1997): 

controlled  clinical study (initiated by Med-Tronik GmbH), conducted with  MORA-Super device (University St. Petersburg and Clinical-scientific  centre St. Petersburg)

AHA evidence level : level 2-3

 

Kofler et al. (1996):

controlled clinical  study – Medline, peer-reviewed (see additional sceptical comment on the interpretation of the results in Galle literature (2002)), conducted with MORA-Super device (University-Derma-clinic Innsbruck)

AHA evidence level: level 3

 

Schöni et al. (1997):

controlled clinical study – Medline, peer-reviewed, conducted with BICOM-device (Alpine children's hospital, Davos)

AHA eveidence level: level 1 

 

Rheumatic

disorders

Gogoleva (2001):

controlled clinical study – Med-line, peer-reviewed, conducted with IMEDIS-device (Institute for policlinical therapy, State Medical Academy, Orenburg)

AHA evidence level: level 3

 

Maiko and Gogoleva (2000):

controlled clinical study – Medline, peer-reviewed, conducted with IMEDIS-devicet (Institute for policlinical therapy, State Medical Academy, Orenburg)

AHA eveidence level: level 2

 

Islamov et al. (2002):

controlled clinical study – Medline, peer-reviewed, conducted with IMEDIS-device (Institute for theoretical and experimental Biophysics and Institute for Rheumatology, Russian Academy of Sciences)

AHA evidence level: level 3

 

Islamov et al. (1999): controlled clinical study – Medline, peer-reviewed, conducted  with IMEDIS-device (Institute for theoretical and experimental Biophysics and Institute for Rheumatology, Russian Academy of sciences)

AHA evidence level: level 3

 

Schuller (2006):

partly controlled study  with clinical test plan and all case reports  (partly sponsored:  MedTronik GMBH), conducted with MORA-Super device, clinical trial.

Published: Schuller and Galle 2007,  Medline, peer-reviewed

AHA evidence level: level 3

 

Obstructive respiratory disorders

Saweljew et al. (2001):

controlled clinical study, conducted with IMEDIS device (Pedeatric Iinstitute, Moskau)

AHA evidence level: level 2

 

Trofimov et al. (1997):

kcontrolled clinical study (initiated by MedTronik GmbH), conducted with MORA-Super device (University St. Petersburg and Clinical-scientific centre  St. Petersburg)

AHA evidence level: level 3

 

Top